Nakae H, Endo S, Inada K, Takakuwa T, Kasai T, Yoshida M
Critical Care and Emergency Center, Iwate Medical University, Morioka, Japan.
Res Commun Chem Pathol Pharmacol. 1994 May;84(2):189-95.
The activities (C3a, C4a, C5a) and concentrations (CH50, C3, C4, C5) of serum complement were measured to evaluate the involvement of complement in sepsis. We studied 27 patients with sepsis who were divided into the survivors (Group 1) and the nonsurvivors (Group 2). The levels of C3a, C4a, and C5a were all significantly higher in Group 2 than in Group 1 and closely reflected the severity of sepsis. Levels of C3 and C4 were significantly lower in Group 2 than in Group 1, presumably because these components were consumed as a result of activation of both the alternative and classical pathways. The levels of CH50 and C5 did not differ significantly between the two groups. These findings suggest that complement is closely involved in the exacerbation of the condition of septic patients, and that the measurement of complement activity is useful for evaluating the severity of sepsis.
检测血清补体的活性(C3a、C4a、C5a)和浓度(CH50、C3、C4、C5)以评估补体在脓毒症中的作用。我们研究了27例脓毒症患者,将其分为存活者(第1组)和非存活者(第2组)。第2组中C3a、C4a和C5a的水平均显著高于第1组,并密切反映了脓毒症的严重程度。第2组中C3和C4的水平显著低于第1组,可能是因为这些成分由于替代途径和经典途径的激活而被消耗。两组之间CH50和C5的水平没有显著差异。这些发现表明补体与脓毒症患者病情的加重密切相关,并且补体活性的检测有助于评估脓毒症的严重程度。